Furthermore, we found that FABP4 expression was positively correlated with ITGB1 and CTNNB1 in MASLD-related HCC patients and MASLD patients at high risk of HCC (Figure 6E and Supplemental Figure 7). This evidence concerns the gene FABP4 and hepatocellular carcinoma.